ELIZABETH GEORGE: Open Payments
NPI 1962990937 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 29 payments from 8 companies in 2025. Trend: 2023 $212 · 2024 $0 · 2025 $505
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $191 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| Janssen Pharmaceuticals, Inc | 3 | $55 |
| Neurocrine BioSciences, Inc. | 3 | $53 |
| Alkermes, Inc. | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: VRAYLAR, REXULTI, COBENFY, INGREZZA, SPRAVATO, ARISTADA, UZEDY, INVEGA SUSTENNA.
Industry payments across OK — which companies pay providers there.
